HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 44 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -47.6% | 17,890 | +326.0% | 0.00% | – |
| Q3 2018 | $21,000 | -65.6% | 4,200 | -77.7% | 0.00% | – |
| Q2 2018 | $61,000 | – | 18,800 | +9300.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 200 | -90.5% | 0.00% | – |
| Q4 2017 | $4,000 | +100.0% | 2,100 | +75.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 1,200 | +140.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 500 | +400.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | -52.4% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 210 | -99.2% | 0.00% | – |
| Q3 2016 | $57,000 | -6.6% | 25,412 | +13.0% | 0.00% | – |
| Q2 2016 | $61,000 | +408.3% | 22,496 | +399.9% | 0.00% | – |
| Q1 2016 | $12,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,675,889 | $6,797,000 | 5.97% |
| PERKINS CAPITAL MANAGEMENT INC | 449,950 | $1,143,000 | 0.89% |
| Diametric Capital, LP | 116,754 | $297,000 | 0.23% |
| Granahan Investment Management | 924,300 | $2,348,000 | 0.17% |
| Requisite Energy Fund I LP | 100,000 | $254,000 | 0.10% |
| Requisite Capital Management, LLC | 100,000 | $254,000 | 0.10% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $635,000 | 0.09% |
| Kalos Management, Inc. | 74,420 | $179,000 | 0.09% |
| Crow Point Partners, LLC | 65,475 | $164,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 35,000 | $89,000 | 0.02% |